OSNA
DEAD

Serial Number

77963067

Owner

SYSMEX CORPORATION

Attorney

Thomas L. Holt

Filing Date

Mar 19, 2010

Add to watchlist:

No watchlists yet
View on USPTO

OSNA Trademark

Serial Number: 77963067 • Registration: 4169649

OSNA is a trademark filed by SYSMEX CORPORATION on March 19, 2010. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SYSMEX CORPORATION (182 trademarks)

1-5-1 WAKINOHAMA-KAIGANDORI
CHUO-KU, KOBE , JP

Entity Type: 03

Trademark Details

Filing Date

March 19, 2010

Registration Date

July 10, 2012

Published for Opposition

April 24, 2012

Cancellation Date

February 15, 2019

Goods & Services

Gene amplification detector for scientific or laboratory use; computers; computer software for use in the field of medical, clinical, diagnostic or laboratory analysis; computer program for use in the field of medical, clinical, diagnostic or laboratory analysis; and structural parts and fittings for the aforementioned goods; all of the foregoing for use with cancer diagnosis

Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for genetic test for medical or veterinary purposes; reagents for amplification and detection of genes for medical and diagnostic use; lymph node solubilizing reagents for medical and diagnostic use; reagents for protein test for medical or veterinary purposes; reagents for cancer recurrence prediction test for medical or veterinary purposes; reagents for anticancer drug sensitivity prediction test for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or veterinary purposes; reference control materials for medical use; chemical reference materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents; and sanitary preparations for medical purposes; all of the foregoing for use with cancer diagnosis

Clinical laboratory testing; clinical laboratory testing of genes for detecting cancer metastasis; providing information about clinical laboratory tests; analysis and evaluation of results of clinical laboratory tests; providing medical information; and rental of medical apparatus and instruments; all of the foregoing for use with cancer diagnosis

Diagnostic or measuring apparatus and instruments for medical purposes, namely, genetic testers, gene amplification detector, cancer metastasis analyzer, cell cycle analyzer, cancer recurrence prediction testers, anticancer drug sensitivity prediction testers, pipettes for medical purposes, containers for samples for in vitro diagnosis, sampling bottles and disposable beakers; and structural parts and fittings for all the aforementioned goods; all of the foregoing for use with cancer diagnosis

Medical and scientific research in the field of cancer diagnosis; providing information about medical research in the field of cancer diagnosis; testing, examination or research of pharmaceutical preparations and diagnostic reagents; testing, examination or research of medical, laboratory, measuring or testing apparatus and instruments; technical advice relating to performance and operation of medical, laboratory, measuring or testing apparatus and instruments and computers that require high levels of personal knowledge, skill or experience of the operators to meet the required accuracy in operating them; rental of gene amplification detector for scientific or laboratory use; rental of laboratory apparatus and instruments; and rental of measuring or testing apparatus and instruments; all of the foregoing for use with cancer diagnosis

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 15, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 10, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 10, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2012 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 16, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2012 CRFA
ASSIGNED TO LIE
Mar 5, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2012 TROA
ASSIGNED TO EXAMINER
Feb 16, 2012 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2011 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2011 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2011 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 17, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 15, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 3, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2011 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 22, 2011 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 21, 2011 GNSL
SUSPENSION LETTER WRITTEN
Jan 21, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2010 CRFA
ASSIGNED TO LIE
Dec 28, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2010 CNRT
ASSIGNED TO EXAMINER
May 26, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Mar 25, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 24, 2010 NWOS
NEW APPLICATION ENTERED
Mar 23, 2010 NWAP